These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease. Lindberg JS Kidney Int Suppl; 2005 Jun; (95):S33-6. PubMed ID: 15882311 [TBL] [Abstract][Full Text] [Related]
6. Suppression of secondary hyperparathyroidism by propranolol in renal failure patients. Besarab A; Caro JF; Ihle BU; Burke JF; Glennon JA; Fischer JA Nephron; 1981; 27(3):127-33. PubMed ID: 7219643 [TBL] [Abstract][Full Text] [Related]
7. A possible role for propranolol in the treatment of renal osteodystrophy. Caro JF; Besarab A; Burke JF; Glennon JA Lancet; 1978 Aug; 2(8087):451-4. PubMed ID: 79809 [TBL] [Abstract][Full Text] [Related]
11. [Renal osteodystrophy and secondary hyperparathyroidism]. Zhu J Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):150. PubMed ID: 7648931 [No Abstract] [Full Text] [Related]
12. Propranolol therapy for secondary hyperparathyroidism in uraemia. Fournier A; Coevoet B; de Fremont JF; Gueris J; Caillens G; Desplan C; Calmette C; Moukhtar MS Lancet; 1978 Jul; 2(8079):50-1. PubMed ID: 78252 [No Abstract] [Full Text] [Related]
13. Parathyroid function in uremic children with and without osteodystrophy. Roof BS; Piel CF; Rames L; Potter D; Gordan GS Pediatrics; 1974 Mar; 53(3):404-9. PubMed ID: 4815261 [No Abstract] [Full Text] [Related]
14. Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia. Makdassi R; Andrejak M; Morinière P; Sebert JL; Decourt S; Guéris J; Coevoet B; Fournier A Adv Exp Med Biol; 1982; 151():667-76. PubMed ID: 7180669 [No Abstract] [Full Text] [Related]
15. Vitamin D therapy in uremic osteodystrophy: theoretical and practical considerations. Popovtzer MM Int J Artif Organs; 1980 Jan; 3(1):1-4. PubMed ID: 7353907 [No Abstract] [Full Text] [Related]
16. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Hörl WH Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V2-8. PubMed ID: 15284353 [TBL] [Abstract][Full Text] [Related]